Literature DB >> 33006226

Recognition of the coronavirus disease 2019 pandemic and face mask wearing in patients with Alzheimer's disease: an investigation at a medical centre for dementia in Japan.

Ryota Kobayashi1,2, Hiroshi Hayashi1,2, Shinobu Kawakatsu2,3, Daichi Morioka1,2, Satomi Aso2, Masayuki Kimura2, Koichi Otani1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33006226      PMCID: PMC7536985          DOI: 10.1111/psyg.12617

Source DB:  PubMed          Journal:  Psychogeriatrics        ISSN: 1346-3500            Impact factor:   2.295


× No keyword cloud information.
COVID‐19 spreads from person to person through saliva droplets and aerosols from exhalation, talking, and a cough. A systematic review and meta‐analysis on the management of severe viral respiratory infections, such as COVID‐19, showed that physical distancing of at least 1 m and wearing a face mask or eye protection reduce the risk of viral infections. Among individuals who do become infected with COVID‐19, those with hypertension, cardiovascular diseases, and diabetes have a greater risk of having a more severe infection. Furthermore, dementia has been shown to pose an increased risk for COVID‐19. Therefore, preventing infection is of vital importance for patients with dementia. However, these patients may have difficulties understanding the risk of COVID‐19 and taking measures against infection either by themselves or with the help of others. The purpose of the present study was to examine recognition of the COVID‐19 pandemic and the status of face mask wearing in patients with Alzheimer's disease (AD). Patients with AD who visited the Medical Center for Dementia at Shinoda General Hospital in Yamagata, Japan, between May 2020 and July 2020 and who fulfilled the criteria for AD by McKhann et al. were enrolled in the study. Patients with severe dementia who could not understand the question of examiner or with a severe reduction in activities of daily living such as eating or moving by themselves were excluded. In total, 55 patients (20 men, 35 women; mean age: 83.4 ± 5.4 years) and their caregivers (family members) participated in this study. The means ± SD of the Mini‐Mental State Examination and Clinical Dementia Rating (CDR) of these patients were 15.9 ± 5.4 and 1.5 ± 0.6, respectively. Semi‐structured interviews on face mask wearing as a preventive measure against COVID‐19 were conducted by a psychiatrist or clinical psychologist. The interview consisted of three questions. Question 1 was ‘Why are you, the examiner, the caregiver, and other patients wearing a face mask?’ If a patient's answer included words or expressions such as ‘coronavirus’, ‘new pneumonia’, and ‘to prevent transmission’, he or she was regarded as recognizing the COVID‐19 pandemic. This question was considered superior to direct questions such as ‘Do you know about the COVID‐19 pandemic?’, which could elicit an erroneous answer as an appearance‐saving response. Question 2 was directed at the caregiver: ‘Does the patient wear a face mask properly or almost properly by himself or herself when necessary?’ If the patient did not wear a face mask properly or almost properly by himself or herself, we asked the caregiver question 3: ‘Can the patient wear a face mask properly or almost properly with your help?’ Statistical analyses were performed with Student's t‐test, Fisher's exact test, and χ2 test, where appropriate, using SPSS version 25 (IBM, Armonk, NY, USA). A P‐value <0.05 was considered statistically significant. The results of the semi‐structured interviews are shown in Table 1. Only 21 of the 55 patients (38.2%) recognized the COVID‐19 pandemic. These patients had a higher mean Mini‐Mental State Examination score and lower mean CDR score than those who did not recognize the COVID‐19 pandemic. Fourteen patients (25.5%) wore a face mask properly by themselves, but 41 patients (74.5%) did not. Patients who wore a face mask on their own had a lower mean CDR score (P = 0.004) and recognized the COVID‐19 pandemic at a higher rate (P = 0.028) than those who did not wear a face mask on their own. Of the 41 patients who did not wear a face mask on their own, 34 (82.9%) could wear one with a caregiver's help. There were no significant differences in mean Mini‐Mental State Examination score, CDR score, or rate of COVID‐19 pandemic recognition between those who could wear a face mask with help and those who could not.
Table 1

Results of semi‐structured interviews with patients and their caregivers

Recognizes COVID‐19 pandemicDoes not recognize COVID‐19 pandemic P‐value
Question 1 (n = 55)21 (38.2%)34 (61.8%)
Age (years)82.2 ± 5.484.1 ± 5.40.200
Men/women7/1413/210.779
Education (years)11.3 ± 2.611.2 ± 2.70.946
MMSE19.9 ± 3.413.5 ± 5.00.000
CDR1.1 ± 0.51.8 ± 0.50.000
Distribution of CDR scores (0.5/1/2/3)3/14/4/00/9/24/10.001
Wears a face mask by themselvesDoes not wear a face mask by themselves
Question 2 (n = 55)14 (25.5%)41 (74.5%)
Age (years)85.0 ± 3.082.8 ± 6.00.081
Men/women4/1016/250.539
Education (years)11.0 ± 2.511.3 ± 2.70.679
MMSE18.4 ± 4.715.1 ± 5.50.054
CDR1.1 ± 0.51.6 ± 0.60.004
Distribution of CDR scores (0.5/1/2/3)2/9/3/01/14/25/10.037
Recognition of COVID‐19 pandemic9 (64.3%)12 (29.3%)0.028
Wears a face mask with caregiver's helpDoes not wear a face mask with caregiver's help
Question 3 (n = 41)34 (82.9%)7 (17.1%)
Age (years)83.5 ± 5.879.6 ± 6.10.124
Men/women15/191/60.215
Education (years)11.4 ± 2.711.1 ± 2.70.834
MMSE15.4 ± 5.513.6 ± 5.40.417
CDR1.6 ± 0.51.9 ± 0.70.271
Distribution of CDR scores (0.5/1/2/3)1/12/21/00/2/4/10.160
Recognition of COVID‐19 pandemic11 (32.4%)1 (14.3%)0.651

Values are presented as mean ± SD, frequency (percentage), or frequency.

MMSE, Mini‐Mental State Examination; CDR, Clinical Dementia Rating; COVID‐19, coronavirus disease 2019.

Results of semi‐structured interviews with patients and their caregivers Values are presented as mean ± SD, frequency (percentage), or frequency. MMSE, Mini‐Mental State Examination; CDR, Clinical Dementia Rating; COVID‐19, coronavirus disease 2019. In our AD patients, the rate of recognition of the COVID‐19 pandemic was only 38.2%. It is reasonable to ascribe this low rate to amnesia, as those who did not recognize the pandemic had the poorestcognitive function scores. However, Mori et al. reported that 86.1% of AD patients were able to recall large earthquakes they experienced (e.g. the Kobe earthquake in 1995). The authors suggested that emotional arousal enhanced episodic memory through the amygdala. It is possible that the COVID‐19 pandemic induces less emotional arousal and retention of episodic memory than large earthquakes experienced. Importantly, 74.5% of the patients did not wear face masks properly by themselves when necessary, most likely because of cognitive impairment, which also limited their pandemic recognition. However, 82.9% of these patients could wear a face mask with the help of their caregivers. This phenomenon was observed regardless of cognitive function score and recognition of the pandemic. It is suggested that instructing caregivers to help patients to wear a face mask is critical in preventing COVID‐19 infection. Last but not least, some of our patients (7/55, 12.7%) could not wear a face mask even with the help of caregivers. For these patients, different measures such as wearing of a face shield may be necessary.

Disclosure

The authors have no conflicts of interest to report.

Ethics Statement

This study was approved by the Ethics Committee of Shinoda General Hospital. Written informed consent was obtained from all patients and their families for inclusion in this study and for publication of this report.
  7 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Amygdalar volume and emotional memory in Alzheimer's disease.

Authors:  E Mori; M Ikeda; N Hirono; H Kitagaki; T Imamura; T Shimomura
Journal:  Am J Psychiatry       Date:  1999-02       Impact factor: 18.112

3.  Are saving appearance responses typical communication patterns in Alzheimer's disease?

Authors:  Masateru Matsushita; Yusuke Yatabe; Asuka Koyama; Akiko Katsuya; Daisuke Ijichi; Yusuke Miyagawa; Hiroto Ikezaki; Noboru Furukawa; Manabu Ikeda; Mamoru Hashimoto
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

4.  Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis.

Authors:  Derek K Chu; Elie A Akl; Stephanie Duda; Karla Solo; Sally Yaacoub; Holger J Schünemann
Journal:  Lancet       Date:  2020-06-01       Impact factor: 79.321

5.  It Is Time to Address Airborne Transmission of Coronavirus Disease 2019 (COVID-19).

Authors:  Lidia Morawska; Donald K Milton
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

6.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

7.  Clinical Presentation of COVID19 in Dementia Patients.

Authors:  A Bianchetti; R Rozzini; F Guerini; S Boffelli; P Ranieri; G Minelli; L Bianchetti; M Trabucchi
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

  7 in total
  5 in total

1.  A Robot-Mediated Activity Using the Nao Robot to Promote COVID-19 Precautionary Measures among Older Adults in Geriatric Facilities.

Authors:  Lauriane Blavette; Anne-Sophie Rigaud; Salvatore Maria Anzalone; Clément Kergueris; Baptiste Isabet; Sébastien Dacunha; Maribel Pino
Journal:  Int J Environ Res Public Health       Date:  2022-04-25       Impact factor: 4.614

Review 2.  COVID-19 and Alzheimer's disease: how one crisis worsens the other.

Authors:  Xiaohuan Xia; Yi Wang; Jialin Zheng
Journal:  Transl Neurodegener       Date:  2021-04-30       Impact factor: 8.014

3.  A cohort study of the impact of COVID-19 on the quality of life of people newly diagnosed with dementia and their family carers.

Authors:  Ben Hicks; Sanna Read; Bo Hu; Raphael Wittenberg; Amanda Grahamslaw; Anomita Karim; Evelyn Martin; Eleanor Nuzum; Jacob Reichental; Alice Russell; Elaine Siddle; Bryony Storey; Eva Tipping; Kate Baxter; Yvonne Birks; Carol Brayne; Nicola Brimblecombe; Margaret Dangoor; Josie Dixon; Kate Gridley; Peter R Harris; Martin Knapp; Eleanor Miles; Rotem Perach; Louise Robinson; Jennifer Rusted; Rob Stewart; Alan J Thomas; Sube Banerjee
Journal:  Alzheimers Dement (N Y)       Date:  2022-05-02

Review 4.  Patient safety implications of wearing a face mask for prevention in the era of COVID-19 pandemic: a systematic review and consensus recommendations.

Authors:  Beatrice Balestracci; Micaela La Regina; Domenico Di Sessa; Nicola Mucci; Francesca Donatella Angelone; Aurelio D'Ecclesia; Vittorio Fineschi; Mariarosaria Di Tommaso; Lorenzo Corbetta; Peter Lachman; Francesco Orlandini; Michela Tanzini; Riccardo Tartaglia; Alessandro Squizzato
Journal:  Intern Emerg Med       Date:  2022-09-14       Impact factor: 5.472

Review 5.  Dementia wellbeing and COVID-19: Review and expert consensus on current research and knowledge gaps.

Authors:  Kathy Y Liu; Robert Howard; Sube Banerjee; Adelina Comas-Herrera; Joanne Goddard; Martin Knapp; Gill Livingston; Jill Manthorpe; John T O'Brien; Ross W Paterson; Louise Robinson; Martin Rossor; James B Rowe; David J Sharp; Andrew Sommerlad; Aida Suárez-González; Alistair Burns
Journal:  Int J Geriatr Psychiatry       Date:  2021-05-27       Impact factor: 3.850

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.